When covered by commercial plans, prior authorization requirements are stringent, often requiring: Documented BMI meeting threshold criteria Failed attempts at lifestyle modification Absence of contraindications Ongoing monitoring and documentation of weight loss progress The list price for tirzepatide is approximately $1,060 per month for either indication (as of 2024), making it financially prohibitive without insurance coverage or manufacturer assistance
Not everyone reaches the maximum dose, but this gives a useful snapshot of what some people experience over the course of treatment
However, notable benefits were observed in other outcomes, including a 31% reduction in hospital admissions for heart failure and a 32% decrease in all-cause mortality ( Other high-profile studies on the use of GLP-1 RAs and SGLT-2 inhibitors combination therapy were conducted by Marfellas et al
Book your DEXA scan now
[DOI] [PubMed] [Google Scholar] 25.Maretty L, et al
Our specialists will assess your health and weight loss goals to determine if Semaglutide is the right choice for you